2008
DOI: 10.1177/147323000803600428
|View full text |Cite
|
Sign up to set email alerts
|

Primary Hepatic Carcinoid Tumours: Clinical Features with an Emphasis on Carcinoid Syndrome and Recurrence

Abstract: This study sought to determine the clinical profiles and optimal management of primary hepatic carcinoid tumours. The clinical features of nine Chinese patients and 64 patients reported in the English-language literature were characterized. Recurrence rate and survival analysis were performed with the Kaplan-Meier method. The impact of surgical resection and post-operative recurrence on survival was determined by means of the log-rank test. Carcinoid syndrome complicated 10 cases (14%). Sixty-two patients (85%… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
44
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(46 citation statements)
references
References 39 publications
2
44
0
Order By: Relevance
“…TACE is recommended for cases with unresectable and/or recurrence tumors, but the long-term survival is not usually good enough. The recurrence rate of PHCT at 5 years after resection was as high as 26% [15]. In our case, the recurrence was shown three years after operation, and then TACE was performed.…”
Section: Discussionmentioning
confidence: 71%
“…TACE is recommended for cases with unresectable and/or recurrence tumors, but the long-term survival is not usually good enough. The recurrence rate of PHCT at 5 years after resection was as high as 26% [15]. In our case, the recurrence was shown three years after operation, and then TACE was performed.…”
Section: Discussionmentioning
confidence: 71%
“…Surgical resection, when feasible, is the preferred treatment (85% of cases), and achieves 5-year survival rates of 80–92.5% [4, 6]. However, recurrences are still very common, which would suggest that patient follow-up of longer than 5 years would be more appropriate [4]. …”
Section: Introductionmentioning
confidence: 99%
“…Recently, work has been conducted to compile published case reports of PHCT in order to obtain an insight into the symptoms, diagnosis, treatment and prognosis of this disease [4,5,6]. Most patients are asymptomatic, but some present with the carcinoid syndrome [4]. Surgical resection, when feasible, is the preferred treatment (85% of cases), and achieves 5-year survival rates of 80–92.5% [4, 6].…”
Section: Introductionmentioning
confidence: 99%
“…Almost 85% of primary hepatic carcinoid tumour patients may have a resectable disease [11,12]. Survival and recurrence tares five years after surgery are of 80-92.5% [8,13] and 18% respectively [14]. When a not well defined lesion is observed, a palliative cyto-reductive surgery in combination with transcatheter arterial embolization (TACE) and subsequent administration of lanreotide (long acting somatostatin analogue) might be effective, as Touloumis et al showed recently [12].…”
Section: Discussionmentioning
confidence: 99%